One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-128404
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 46 |
Affiliation: The Ohio State University, St James's University Hospital, Willamette Valley Cancer Institute and Research Center, Swedish Medical Center, Universidade Federal do Rio Grande do Sul, Monash University, Alfred Health, Stanford University, Stanford Medicine, The University of Texas MD Anderson Cancer Center, Novant Health, Hackensack University Medical Center, Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, Research Institute in Oncology and Hematology, University of Manitoba, Skåne University Hospital, Royal Bournemouth Hospital, Somogy Megyei Kaposi Mór Oktató Kórház, Tauranga Hospital, University of Colorado Cancer Center, University of Colorado Denver, KU Leuven, Jagiellonian University, Hôpital Lyon Sud, Addenbrooke's Hospital, Tel Aviv University, Tel Aviv Sourasky Medical CenterELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
